These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10225369)

  • 1. Algogenic mediator-induced nociceptive response in diabetic mice.
    Kamei J; Kashiwazaki T; Taki K; Hitosugi H; Nagase H
    Eur J Pharmacol; 1999 Mar; 369(3):319-23. PubMed ID: 10225369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice.
    Kamei J; Kashiwazaki T; Hitosugi H; Nagase H
    Eur J Pharmacol; 1997 May; 326(1):31-6. PubMed ID: 9178652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formalin-induced nociceptive responses in diabetic mice.
    Kamei J; Hitosugi H; Kasuya Y
    Neurosci Lett; 1993 Jan; 149(2):161-4. PubMed ID: 7682680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mexiletine on algogenic mediator-induced nociceptive responses in mice.
    Hitosugi H; Kashiwazaki T; Ohsawa M; Kamei J
    Methods Find Exp Clin Pharmacol; 1999; 21(6):409-13. PubMed ID: 10445233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diabetes on pinacidil-induced antinociception in mice.
    Zushida K; Onodera K; Kamei J
    Eur J Pharmacol; 2002 Oct; 453(2-3):209-15. PubMed ID: 12398906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effect of dihydroetorphine in diabetic mice.
    Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mexiletine on formalin-induced nociceptive responses in mice.
    Kamei J; Hitosugi H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):153-62. PubMed ID: 7686682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of diabetes on spontaneous locomotor activity in mice.
    Kamei J; Saitoh A; Iwamoto Y; Funada M; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Neurosci Lett; 1994 Aug; 178(1):69-72. PubMed ID: 7816344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of delta1-opioid receptors in the spatial learning impairment in streptozotocin-induced diabetic mice.
    Kamei J; Miyata S; Takahashi M; Saitoh A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Oct; 25(5):221-5. PubMed ID: 16313098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nociceptive responses to intrathecally administered substance P and somatostatin in diabetic mice.
    Kamei J; Hitosugi H; Kasuya Y
    Life Sci; 1993; 52(4):PL31-6. PubMed ID: 7678435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of endogenous opioid peptides in modulation of nocifensive response to formalin.
    Wu HE; Hung KC; Mizoguchi H; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2002 Feb; 300(2):647-54. PubMed ID: 11805228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive effect of L-arginine in diabetic mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1994 Mar; 254(1-2):113-7. PubMed ID: 8206107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of spinal delta 1-opioid receptors in forced walking stress-induced antinociception in the tail-flick test in mice.
    Kamei J; Taki K; Ohsawa M; Nagase H; Onodera K
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):595-8. PubMed ID: 10669903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
    Kamei J; Ohsawa M; Kashiwazaki T; Nagase H
    Eur J Pharmacol; 1999 Apr; 370(2):109-16. PubMed ID: 10323258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential mediation of cold water swim stress-induced antinociception by delta-opioid receptor subtypes in diabetic mice.
    Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Life Sci; 1994; 54(23):PL425-30. PubMed ID: 8196487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Kamei J
    Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supraspinal delta 1-opioid receptor-mediated antinociceptive properties of (-)-TAN-67 in diabetic mice.
    Kamei J; Kawai K; Mizusuna A; Saitoh A; Morita K; Narita M; Tseng LF; Nagase H
    Eur J Pharmacol; 1997 Mar; 322(1):27-30. PubMed ID: 9088866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
    Reeta Kh; Mediratta PK; Rathi N; Jain H; Chugh C; Sharma KK
    Regul Pept; 2006 Jul; 135(1-2):85-90. PubMed ID: 16712978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J; Zushida K; Ohsawa M; Nagase H
    Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effect of lipopolysaccharide from Pantoea agglomerans on streptozotocin-induced diabetic mice.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Kasuya Y; Nagase H; Okutomi T; Soma G; Mizuno D
    Eur J Pharmacol; 1994 Jan; 251(1):95-8. PubMed ID: 8137875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.